Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × lenvatinib × 30 days × Clear all

Sponsor

Conditions

Endometrial Neoplasms 5 Carcinoma, Renal Cell 5 Carcinoma, Hepatocellular 5 Thyroid Neoplasms 3 Cholangiocarcinoma 3 Uterine Cervical Neoplasms 2 Neoplasms 2 Biliary Tract Neoplasms 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 Liver Neoplasms 1 Hematologic Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Differentiated Thyroid Cancer 1 Colorectal Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Malignancies 1 Adenocarcinoma 1

Interventions

X-Rays 2 Specimen Handling 2 Phantoms, Imaging 2 Nuclear Medicine Department, Hospital 2 Magnetic Resonance Spectroscopy 2 Biopsy 2 temsirolimus 1 erdafitinib 1 ensartinib 1 Vincristine 1 Temozolomide 1 Surgical Procedures, Operative 1 Sorafenib 1 Radiation 1 Proton Therapy 1 Ifosfamide 1 Etoposide 1 Doxorubicin 1 Cyclophosphamide 1 Brachytherapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡